AI Article Synopsis

  • Klebsiella pneumoniae (Kp) is a significant opportunistic pathogen contributing to antimicrobial resistance, making effective treatments crucial.
  • Researchers have developed a new strategy for isolating anti-K phages by using capsule-deficient Kp mutants, which allows these phages to infect a broader range of Kp strains.
  • This approach shows promise for overcoming limitations related to Kp's highly diverse capsules and could enhance the effectiveness of phage therapy, particularly in treating Kp infections in complex environments like the gut.

Article Abstract

Klebsiella pneumoniae (Kp), a human gut colonizer and opportunistic pathogen, is a major contributor to the global burden of antimicrobial resistance. Virulent bacteriophages represent promising agents for decolonization and therapy. However, the majority of anti-Kp phages that have been isolated thus far are highly specific to unique capsular types (anti-K phages), which is a major limitation to phage therapy prospects due to the highly polymorphic capsule of Kp. Here, we report on an original anti-Kp phage isolation strategy, using capsule-deficient Kp mutants as hosts (anti-K phages). We show that anti-K phages have a broad host range, as the majority are able to infect noncapsulated mutants of multiple genetic sublineages and O-types. Additionally, anti-K phages induce a lower rate of resistance emergence and provide increased killing efficiency when in combination with anti-K phages. , anti-K phages are able to replicate in mouse guts colonized with a capsulated Kp strain, suggesting the presence of noncapsulated Kp subpopulations. The original strategy proposed here represents a promising avenue that circumvents the Kp capsule host restriction barrier, offering promise for therapeutic development. Klebsiella pneumoniae (Kp) is an ecologically generalist bacterium as well as an opportunistic pathogen that is responsible for hospital-acquired infections and a major contributor to the global burden of antimicrobial resistance. In the last decades, limited advances have been made in the use of virulent phages as alternatives or complements to antibiotics that are used to treat Kp infections. This work demonstrates the potential value of an anti-Klebsiella phage isolation strategy that addresses the issue of the narrow host range of anti-K phages. Anti-K phages may be active in infection sites in which capsule expression is intermittent or repressed or in combination with anti-K phages, which often induce the loss of capsule in escape mutants.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433977PMC
http://dx.doi.org/10.1128/spectrum.04812-22DOI Listing

Publication Analysis

Top Keywords

anti-k phages
36
phages
12
klebsiella pneumoniae
12
host range
12
phages anti-k
12
anti-k
9
opportunistic pathogen
8
major contributor
8
contributor global
8
global burden
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!